Umbilical Cord Mesenchymal Stem Cells transplantation

BIOLOGICAL2 trials

Sponsors

Vinmec Research Institute of Stem Cell and Gene Technology

Conditions

COPDFrailty

Phase 1

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

CompletedNCT04433104

Vinmec Research Institute of Stem Cell and Gene TechnologyCOPD

Start: 2020-06-09End: 2022-12-25Updated: 2024-06-04

Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty

CompletedNCT04919135

Vinmec Research Institute of Stem Cell and Gene TechnologyFrailty

Start: 2021-10-19End: 2024-12-30Updated: 2025-08-17

Related Papers

Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma.

2024-02-2713 citations

Clinical Study of Mesenchymal Stem/Stromal Cell Therapy for the Treatment of Frailty: A Proposed Experimental Design for Therapeutic and Mechanistic Investigation

The Journals of Gerontology Series A2021-10-283 citations

Allogeneic human umbilical cord-derived mesenchymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case–control, phase I/II trial

BMJ Open2021-05-0111 citations